| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.2 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.2 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.2 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.2 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.18 | 0.2 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.072 | 0.2 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |